华北制药 - Financials

华北制药 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
+Revenue	9.9B	10.1B	10.5B	10.4B	11.5B	11.5B	9.2B	7.7B	8.1B	7.9B	9.4B	12.4B	11.1B	12.3B	10.3B	4.9B	4.9B	4.2B	4.0B	4.0B
Revenue Growth %	-2.5%	-3.6%	1.1%	-9.6%	0.3%	24.3%	19.5%	-4.6%	2.3%	-15.9%	-24.5%	11.8%	-9.2%	19.1%	108.0%	0.6%	15.9%	6.0%	0.7%	--
Total Revenue	9.9B	10.1B	10.5B	10.4B	11.5B	11.5B	9.2B	7.7B	8.1B	7.9B	9.4B	12.4B	11.1B	12.3B	10.3B	4.9B	4.9B	4.2B	4.0B	4.0B
Cost Of Revenue	6.7B	6.9B	7.0B	6.7B	7.4B	6.7B	5.3B	5.3B	6.5B	6.5B	7.9B	11.2B	10.1B	11.1B	8.8B	3.4B	3.2B	3.0B	3.3B	3.2B
+Gross Profit	3.2B	3.2B	3.5B	3.7B	4.1B	4.7B	3.9B	2.4B	1.6B	1.4B	1.5B	1.3B	1.1B	1.1B	1.5B	1.5B	1.7B	1.2B	730.0M	751.0M
Gross Margin %	32.0%	32.0%	33.4%	35.5%	35.8%	41.2%	42.2%	31.7%	19.4%	18.2%	16.2%	10.3%	9.6%	9.0%	14.8%	30.9%	34.6%	28.5%	18.2%	18.9%
Total Operating Cost	9.6B	10.1B	11.2B	10.4B	11.5B	11.3B	9.2B	7.7B	8.1B	7.9B	9.4B	12.6B	11.4B	12.6B	10.0B	5.3B	4.5B	4.1B	4.1B	4.2B
Selling Expenses	1.4B	1.7B	1.8B	2.2B	2.7B	3.2B	2.6B	1.4B	759.0M	710.0M	758.0M	631.0M	517.0M	535.0M	373.0M	318.0M	279.0M	291.0M	236.0M	275.0M
Admin Expenses	582.0M	630.0M	586.0M	641.0M	498.0M	510.0M	488.0M	422.0M	485.0M	433.0M	477.0M	492.0M	653.0M	662.0M	647.0M	687.0M	572.0M	439.0M	316.0M	426.0M
Rd Expenses	337.0M	297.0M	217.0M	153.0M	136.0M	84.8M	76.4M	47.4M	--	--	--	--	--	--	--	--	--	--	--	--
Finance Expenses	426.0M	473.0M	552.0M	576.0M	577.0M	527.0M	432.0M	379.0M	279.0M	251.0M	289.0M	202.0M	183.0M	221.0M	216.0M	218.0M	294.0M	278.0M	244.0M	229.0M
+Operating Income	312.0M	156.0M	-568.0M	136.0M	184.0M	265.0M	205.0M	104.0M	-14.0M	10.1M	-24.9M	-115.0M	-263.0M	-360.0M	277.0M	-309.0M	420.0M	149.0M	-34.5M	-189.0M
Operating Margin %	3.2%	1.5%	-5.4%	1.3%	1.6%	2.3%	2.2%	1.3%	-0.2%	0.1%	-0.3%	-0.9%	-2.4%	-2.9%	2.7%	-6.2%	8.5%	3.5%	-0.9%	-4.8%
Non Operating Income	6.9M	10.2M	4.1M	7.0M	7.0M	4.0M	1.8M	3.9M	97.2M	66.2M	168.0M	142.0M	297.0M	534.0M	92.7M	53.1M	10.7M	7.6M	42.0M	6.1M
Non Operating Expenses	8.8M	8.1M	1.6M	8.2M	4.5M	8.2M	8.3M	48.3M	5.0M	3.1M	90.2M	3.1M	8.1M	4.0M	7.7M	14.1M	11.2M	12.3M	2.9M	5.9M
Investment Income	46.2M	46.9M	44.0M	39.1M	26.4M	34.5M	40.3M	37.5M	31.0M	41.4M	30.4M	22.9M	47.7M	32.9M	10.8M	34.6M	17.6M	15.8M	34.7M	-11.8M
Asset Disposal Income	444,200	755,800	443,200	3.0M	2.3M	480,400	744,200	2.0M	21.7M	--	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	16.4M	14.5M	65.9M	-13.1M	25.0M	-10.5M	84.7M	86.9M	26.4M	35.1M	25.2M	58.8M	1.9M	43.4M	-13.2M	629.0M	132.0M	48.3M	-13.4M	--
Other Income	36.7M	47.0M	38.8M	72.3M	137.0M	50.0M	136.0M	39.5M	--	--	--	--	--	--	--	--	--	--	--	--
Income Before Tax	310.0M	159.0M	-565.0M	135.0M	187.0M	261.0M	198.0M	59.6M	78.1M	73.2M	52.6M	23.8M	25.1M	169.0M	362.0M	-270.0M	419.0M	144.0M	4.6M	-188.0M
Income Tax	94.9M	109.0M	114.0M	99.5M	82.2M	94.0M	52.6M	45.1M	26.5M	22.4M	23.9M	14.3M	11.0M	11.2M	100.0M	118.0M	134.0M	70.2M	2.7M	29.1M
+Net Income	215.0M	49.4M	-679.0M	35.4M	104.0M	167.0M	146.0M	14.4M	51.6M	50.9M	28.7M	9.5M	14.1M	158.0M	262.0M	-387.0M	285.0M	74.1M	1.9M	-169.0M
Net Margin %	2.2%	0.5%	-6.5%	0.3%	0.9%	1.5%	1.6%	0.2%	0.6%	0.6%	0.3%	0.1%	0.1%	1.3%	2.5%	-7.8%	5.8%	1.7%	0.0%	-4.3%
Net Income Attributable	127.0M	4.9M	-689.0M	18.7M	97.3M	172.0M	151.0M	18.8M	54.4M	62.8M	38.5M	13.7M	17.8M	138.0M	242.0M	-368.0M	279.0M	60.5M	-12.0M	-185.0M
Minority Interest	88.0M	44.5M	10.4M	16.7M	7.2M	-5.5M	-4.8M	-4.3M	-2.8M	-12.0M	-9.8M	-4.2M	-3.7M	19.9M	20.0M	-19.4M	5.9M	13.6M	13.9M	15.5M
Eps Basic	0.07	0.00	-0.40	0.01	0.06	0.11	0.09	0.01	0.03	0.04	0.03	0.01	0.02	0.14	0.24	-0.36	0.27	0.06	-0.01	-0.25
Eps Diluted	0.07	0.00	-0.40	0.01	0.06	0.11	0.09	0.01	0.03	0.04	0.03	0.01	0.02	0.14	0.24	-0.36	0.27	0.06	-0.01	--

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash And Equivalents	1.7B	988.0M	1.7B	5.3B	4.9B	1.3B	1.2B	1.1B	1.3B	1.2B	1.3B	1.0B	1.6B	1.5B	978.0M	1.7B	1.2B	471.0M	657.0M	486.0M
Trading Financial Assets	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	2.0B	1.9B	2.2B	2.0B	1.7B	1.6B	1.2B	1.2B	1.3B	1.2B	1.4B	1.8B	1.3B	1.2B	881.0M	669.0M	1.0B	1.3B	1.6B	1.3B
Notes Receivable	--	--	26.0M	87.6M	97.1M	146.0M	109.0M	167.0M	246.0M	224.0M	271.0M	274.0M	238.0M	132.0M	593.0M	301.0M	200.0M	160.0M	172.0M	130.0M
Notes And Accounts Receivable	2.0B	1.9B	2.3B	2.0B	1.8B	1.7B	1.3B	1.4B	1.6B	1.5B	1.7B	2.1B	1.5B	1.3B	1.5B	971.0M	1.2B	1.5B	1.8B	1.5B
Prepayments	213.0M	282.0M	269.0M	211.0M	203.0M	161.0M	142.0M	169.0M	196.0M	166.0M	162.0M	154.0M	179.0M	157.0M	92.9M	190.0M	210.0M	176.0M	133.0M	73.4M
Inventory	2.5B	2.6B	2.5B	2.4B	2.5B	2.2B	2.1B	1.7B	1.5B	1.7B	1.7B	1.5B	1.4B	1.4B	1.2B	808.0M	826.0M	906.0M	733.0M	942.0M
Total Current Assets	8.3B	8.0B	9.0B	12.7B	12.1B	8.1B	7.4B	6.8B	6.7B	6.5B	5.9B	5.6B	5.3B	4.8B	4.0B	3.7B	3.6B	3.1B	3.4B	3.5B
Long Term Equity Investment	1.2B	1.2B	901.0M	858.0M	582.0M	575.0M	659.0M	652.0M	415.0M	385.0M	357.0M	258.0M	255.0M	274.0M	272.0M	327.0M	339.0M	323.0M	347.0M	336.0M
Fixed Assets	--	6.4B	6.7B	6.7B	--	7.9B	7.8B	7.9B	7.0B	6.0B	6.1B	6.1B	4.6B	2.6B	2.6B	2.5B	2.6B	2.7B	2.8B	2.9B
Fixed Assets Total	6.3B	6.4B	6.8B	6.7B	7.9B	8.0B	7.8B	7.9B	7.0B	6.1B	6.1B	6.1B	4.6B	2.8B	2.6B	2.5B	2.6B	2.7B	2.8B	2.9B
Construction In Progress	--	162.0M	155.0M	672.0M	618.0M	491.0M	654.0M	614.0M	1.4B	2.1B	2.4B	1.9B	2.8B	3.3B	1.9B	550.0M	177.0M	155.0M	118.0M	107.0M
Construction In Progress Total	381.0M	162.0M	155.0M	672.0M	618.0M	491.0M	654.0M	614.0M	1.4B	2.1B	2.4B	1.9B	2.8B	3.3B	1.9B	551.0M	177.0M	156.0M	135.0M	107.0M
Intangible Assets	2.8B	2.0B	1.6B	1.3B	1.2B	475.0M	376.0M	336.0M	348.0M	352.0M	321.0M	330.0M	315.0M	272.0M	252.0M	251.0M	256.0M	247.0M	203.0M	105.0M
Long Term Deferred Expenses	66.1M	53.2M	59.4M	27.1M	46.8M	62.4M	56.4M	60.6M	14.6M	20.0M	26.6M	29.3M	32.7M	24.9M	10.4M	9.7M	13.5M	13.7M	10.0M	13.4M
Total Non Current Assets	13.2B	12.9B	12.2B	12.2B	11.8B	10.8B	10.6B	10.3B	9.8B	9.5B	9.7B	9.0B	8.3B	6.8B	5.1B	3.7B	3.4B	3.5B	3.6B	3.5B
Total Assets	21.5B	21.0B	21.2B	24.9B	23.9B	18.9B	17.9B	17.2B	16.5B	16.0B	15.6B	14.6B	13.5B	11.6B	9.1B	7.4B	7.1B	6.7B	7.1B	6.9B
Short Term Borrowings	7.1B	5.5B	5.3B	7.6B	6.8B	6.4B	4.6B	3.2B	3.5B	1.4B	2.4B	2.1B	1.1B	3.1B	2.6B	3.0B	3.7B	3.6B	4.0B	3.3B
Accounts Payable	1.8B	1.9B	2.0B	2.1B	2.1B	2.0B	1.9B	1.6B	1.7B	2.0B	2.2B	2.0B	1.6B	1.5B	924.0M	652.0M	590.0M	691.0M	683.0M	723.0M
Advance Receipts	--	--	--	--	--	237.0M	214.0M	225.0M	193.0M	186.0M	218.0M	259.0M	163.0M	126.0M	150.0M	81.5M	145.0M	139.0M	87.8M	61.8M
Contract Liabilities	282.0M	313.0M	296.0M	258.0M	269.0M	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	11.0B	10.3B	12.4B	14.2B	11.8B	10.3B	10.7B	8.7B	9.1B	7.9B	8.8B	7.1B	5.7B	6.6B	4.8B	4.5B	5.5B	5.2B	5.6B	5.5B
Long Term Borrowings	3.5B	4.1B	2.1B	3.3B	4.6B	1.6B	790.0M	2.0B	1.7B	2.4B	1.0B	2.6B	2.8B	3.1B	2.2B	975.0M	14.0M	--	20.0M	15.0M
Total Non Current Liabilities	3.8B	4.4B	2.6B	3.7B	5.1B	2.8B	1.7B	3.2B	2.1B	2.8B	1.5B	3.3B	3.7B	3.6B	3.1B	1.9B	23.6M	27.1M	47.1M	42.0M
Total Liabilities	14.8B	14.7B	15.0B	17.9B	16.9B	13.2B	12.4B	11.9B	11.2B	10.7B	10.3B	10.4B	9.4B	10.2B	7.9B	6.4B	5.5B	5.2B	5.6B	5.6B
Paid In Capital	1.7B	1.7B	1.7B	1.7B	1.6B	1.6B	1.6B	1.6B	1.6B	1.6B	1.6B	1.4B	1.4B	1.0B	1.0B	1.0B	1.0B	1.0B	1.0B	762.0M
Capital Reserve	3.9B	3.9B	3.9B	3.9B	4.0B	3.6B	3.5B	3.5B	3.5B	3.5B	3.5B	2.6B	2.6B	119.0M	54.2M	162.0M	280.0M	256.0M	256.0M	525.0M
Surplus Reserve	333.0M	322.0M	295.0M	292.0M	278.0M	258.0M	236.0M	216.0M	213.0M	193.0M	185.0M	180.0M	171.0M	151.0M	126.0M	111.0M	84.6M	212.0M	212.0M	212.0M
Retained Earnings	-530.0M	-629.0M	-607.0M	188.0M	232.0M	202.0M	86.5M	-27.5M	-10.6M	-12.6M	-66.8M	-99.6M	-53.4M	-51.1M	-190.0M	-415.0M	-42.3M	-250.0M	-293.0M	-263.0M
Minority Equity	1.3B	955.0M	928.0M	932.0M	931.0M	64.0M	69.6M	-25.8M	-21.5M	-18.7M	42.6M	107.0M	106.0M	209.0M	163.0M	87.9M	225.0M	209.0M	225.0M	204.0M
Equity Attributable	5.4B	5.3B	5.3B	6.1B	6.1B	5.7B	5.4B	5.3B	5.3B	5.3B	5.2B	4.0B	4.1B	1.2B	1.0B	886.0M	1.4B	1.2B	1.2B	1.2B
Total Equity	6.7B	6.3B	6.2B	7.0B	7.1B	5.8B	5.5B	5.3B	5.3B	5.3B	5.3B	4.1B	4.2B	1.5B	1.2B	974.0M	1.6B	1.5B	1.4B	1.4B

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008	FY 2007Dec 31, 2007	FY 2006Dec 31, 2006	FY 2005Dec 31, 2005
Cash From Sales	7.6B	8.5B	10.0B	8.9B	9.9B	9.3B	7.9B	6.2B	6.5B	6.1B	7.2B	10.2B	5.4B	5.0B	5.2B	3.9B	4.2B	3.5B	2.8B	4.2B
Tax Refunds Received	106.0M	102.0M	153.0M	139.0M	121.0M	99.8M	94.8M	65.8M	70.9M	102.0M	104.0M	232.0M	212.0M	171.0M	132.0M	62.6M	81.0M	54.7M	65.7M	39.1M
Total Operating Cash Inflow	7.9B	8.8B	10.4B	9.4B	10.5B	9.7B	8.3B	6.6B	7.0B	6.6B	7.7B	11.1B	6.1B	5.6B	5.7B	4.7B	4.5B	3.6B	3.4B	4.3B
Cash Paid For Goods	3.3B	4.0B	5.4B	4.3B	4.6B	3.6B	3.1B	3.4B	4.5B	4.1B	5.3B	9.0B	4.1B	3.3B	4.3B	2.2B	1.9B	1.7B	1.8B	3.0B
Cash Paid To Employees	1.4B	1.4B	1.5B	1.2B	1.3B	1.3B	1.1B	1.1B	1.0B	962.0M	1.0B	1.0B	1.1B	1.0B	917.0M	663.0M	572.0M	465.0M	436.0M	460.0M
Taxes Paid	495.0M	608.0M	569.0M	609.0M	665.0M	765.0M	693.0M	620.0M	448.0M	314.0M	285.0M	243.0M	273.0M	299.0M	442.0M	362.0M	394.0M	254.0M	208.0M	188.0M
Total Operating Cash Outflow	6.6B	7.7B	9.4B	8.3B	9.7B	8.9B	7.6B	6.3B	7.4B	6.5B	7.6B	11.3B	6.1B	5.3B	6.3B	3.7B	3.4B	2.9B	2.8B	4.1B
Operating Cash Flow	1.2B	1.0B	1.0B	1.1B	752.0M	764.0M	774.0M	287.0M	-447.0M	122.0M	93.6M	-135.0M	-63.9M	272.0M	-598.0M	1.0B	1.1B	664.0M	571.0M	224.0M
Total Investing Cash Inflow	512.0M	1.3M	23.1M	8.2M	163.0M	76.0M	37.7M	18.9M	42.5M	1.2M	288,300	24.3M	40.7M	41.2M	78.0M	81.4M	8.2M	3.0M	71.4M	78.9M
Total Investing Cash Outflow	1.5B	883.0M	552.0M	787.0M	1.0B	670.0M	507.0M	600.0M	289.0M	368.0M	324.0M	561.0M	1.3B	1.2B	1.2B	718.0M	170.0M	106.0M	19.8M	294.0M
Investing Cash Flow	-947.0M	-882.0M	-528.0M	-779.0M	-844.0M	-594.0M	-469.0M	-581.0M	-246.0M	-367.0M	-324.0M	-537.0M	-1.3B	-1.2B	-1.1B	-636.0M	-161.0M	-103.0M	51.6M	-215.0M
Cash From Borrowings	9.8B	9.8B	10.3B	10.3B	15.0B	9.9B	7.2B	6.6B	4.5B	5.0B	4.3B	3.3B	6.2B	5.1B	4.6B	4.5B	4.9B	3.9B	5.2B	4.3B
Dividends And Interest Paid	493.0M	516.0M	742.0M	747.0M	657.0M	624.0M	520.0M	409.0M	451.0M	397.0M	350.0M	441.0M	428.0M	327.0M	213.0M	277.0M	295.0M	274.0M	277.0M	284.0M
Debt Repayments	9.6B	9.6B	13.2B	9.5B	11.5B	10.8B	8.0B	8.2B	5.5B	6.4B	5.4B	2.6B	7.1B	3.8B	3.4B	4.3B	4.8B	4.4B	5.4B	4.2B
Total Financing Cash Inflow	11.7B	10.8B	11.5B	11.4B	16.8B	12.4B	8.6B	9.1B	6.9B	7.0B	6.4B	3.3B	9.2B	5.5B	4.6B	4.6B	4.9B	3.9B	5.2B	4.3B
Total Financing Cash Outflow	11.2B	11.5B	16.0B	11.1B	13.3B	12.5B	8.8B	9.1B	6.2B	6.8B	6.0B	3.2B	7.7B	4.2B	3.6B	4.6B	5.0B	4.7B	5.7B	4.5B
Financing Cash Flow	463.0M	-704.0M	-4.5B	315.0M	3.4B	-92.2M	-207.0M	50.7M	657.0M	200.0M	387.0M	120.0M	1.5B	1.3B	1.0B	26.8M	-186.0M	-740.0M	-504.0M	-161.0M
Net Change In Cash	757.0M	-550.0M	-4.0B	582.0M	3.3B	81.0M	98.6M	-251.0M	-29.5M	-34.2M	159.0M	-554.0M	113.0M	418.0M	-679.0M	404.0M	754.0M	-185.0M	117.0M	-155.0M
Ending Cash Balance	1.3B	505.0M	1.1B	5.0B	4.5B	1.1B	994.0M	895.0M	1.1B	1.2B	1.2B	1.0B	1.6B	1.5B	978.0M	1.7B	1.2B	471.0M	657.0M	--
Capex	784.0M	623.0M	550.0M	547.0M	1.0B	670.0M	507.0M	400.0M	289.0M	368.0M	262.0M	561.0M	1.1B	1.1B	1.2B	372.0M	160.0M	98.3M	19.8M	185.0M